Sažetak
Background: Patients with type 2 diabetes mellitus (T2DM) often suffer from atherosclerosis, and timely stratification of patient risk is crucial for preventing cardiovascular events.
Objectives: It aimed to explore the correlation between electrocardiogram (ECG) characteristics, pulse wave velocity (PWV), blood lipid levels, and novel serum biomarkers with carotid atherosclerosis (CAS) in T2DM patients, providing a multidimensional assessment basis for early identification of high-risk patients.
Methods: A retrospective study included 201 T2DM patients at Zhongshan Hospital (Xiamen), Fudan University from January 2024 to December 2025. Patients were allocated to control group (AG, 91 cases with normal carotid arteries or only intimal thickening) or observation group (BG, 110 cases with carotid plaques). General data, ECG indicators, vascular function indicators, blood glucose, blood lipid levels, low-sensitivity C-reactive protein (CRP-L), and novel serum biomarkers (adiponectin, leptin, sICAM-1, IL-6, FGF-21) were collected.
Results: The BG had significantly longer P wave duration (PR) and corrected QT (QTc)interval, with higher PWV-Left and PWV-Right; Fasting plasma glucose (FPG), triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels were lower, and glycated hemoglobin (HbA1c) and CRP-L were significantly elevated in the BG (P <0.05). Additionally, serum levels of adiponectin were significantly lower, while leptin, sICAM-1, and IL-6 were higher in the BG compared to AG (*P < 0.05). PR, QT, PWV (left/right), FPG, HbA1c, TG, TC, LDL-C, CRP-L, and several serum biomarkers were independent influencing factors for CAS.
Conclusion: In T2DM patients, ECG repolarization abnormalities, increased arterial stiffness, poor long-term glycemic control, chronic low-grade inflammation, and alterations in novel serum biomarkers are closely related to CAS. Comprehensive assessment of ECG, PWV, inflammatory-metabolic markers, and emerging serum biomarkers helps more accurately identify high-risk populations for atherosclerosis.
Ključne reči
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.